Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rett Syndrome | 18 | 2025 | 228 | 4.560 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 15 | 2026 | 283 | 2.440 |
Why?
|
| Spasms, Infantile | 11 | 2025 | 165 | 1.820 |
Why?
|
| Epileptic Syndromes | 10 | 2025 | 35 | 1.710 |
Why?
|
| Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2026 | 11 | 0.970 |
Why?
|
| Congenital Disorders of Glycosylation | 1 | 2026 | 50 | 0.930 |
Why?
|
| Autistic Disorder | 5 | 2026 | 394 | 0.710 |
Why?
|
| Mutation | 8 | 2026 | 6146 | 0.620 |
Why?
|
| Walking | 2 | 2020 | 215 | 0.570 |
Why?
|
| Psychometrics | 6 | 2024 | 671 | 0.480 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2018 | 326 | 0.470 |
Why?
|
| Repressor Proteins | 2 | 2026 | 771 | 0.450 |
Why?
|
| Child | 26 | 2026 | 26213 | 0.430 |
Why?
|
| Phenotype | 7 | 2026 | 4478 | 0.420 |
Why?
|
| Gait | 3 | 2025 | 133 | 0.390 |
Why?
|
| Child, Preschool | 16 | 2026 | 15011 | 0.390 |
Why?
|
| Caregivers | 6 | 2024 | 573 | 0.390 |
Why?
|
| Autism Spectrum Disorder | 3 | 2022 | 439 | 0.370 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 1215 | 0.360 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2024 | 242 | 0.350 |
Why?
|
| Quality of Life | 8 | 2025 | 2089 | 0.340 |
Why?
|
| Female | 25 | 2026 | 70618 | 0.310 |
Why?
|
| Surveys and Questionnaires | 10 | 2024 | 4037 | 0.310 |
Why?
|
| Parents | 4 | 2024 | 1109 | 0.300 |
Why?
|
| Carotid Artery, Internal, Dissection | 1 | 2009 | 7 | 0.300 |
Why?
|
| Humans | 40 | 2026 | 130749 | 0.300 |
Why?
|
| Adolescent | 15 | 2026 | 20832 | 0.300 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2009 | 38 | 0.300 |
Why?
|
| Severity of Illness Index | 5 | 2025 | 3062 | 0.270 |
Why?
|
| Infant | 11 | 2026 | 13321 | 0.260 |
Why?
|
| Body Patterning | 1 | 2007 | 128 | 0.260 |
Why?
|
| Organogenesis | 1 | 2007 | 80 | 0.260 |
Why?
|
| Young Adult | 11 | 2025 | 10021 | 0.260 |
Why?
|
| Neurons | 3 | 2024 | 1995 | 0.250 |
Why?
|
| Neocortex | 1 | 2007 | 74 | 0.250 |
Why?
|
| Electroencephalography | 3 | 2025 | 861 | 0.240 |
Why?
|
| Biomechanical Phenomena | 3 | 2025 | 257 | 0.240 |
Why?
|
| Seizures | 3 | 2025 | 885 | 0.230 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2025 | 44 | 0.230 |
Why?
|
| Gene Duplication | 3 | 2024 | 361 | 0.220 |
Why?
|
| Male | 17 | 2026 | 64669 | 0.220 |
Why?
|
| Reproducibility of Results | 7 | 2024 | 2937 | 0.220 |
Why?
|
| Intellectual Disability | 2 | 2022 | 1076 | 0.220 |
Why?
|
| Prospective Studies | 2 | 2026 | 6494 | 0.220 |
Why?
|
| Epilepsy | 3 | 2022 | 878 | 0.210 |
Why?
|
| 5' Untranslated Regions | 1 | 2024 | 57 | 0.210 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2024 | 72 | 0.210 |
Why?
|
| Sensation Disorders | 1 | 2024 | 20 | 0.210 |
Why?
|
| Internationality | 1 | 2024 | 128 | 0.210 |
Why?
|
| Chromosomes, Human, X | 2 | 2026 | 155 | 0.200 |
Why?
|
| Mosaicism | 1 | 2024 | 250 | 0.190 |
Why?
|
| Stem Cells | 1 | 2007 | 710 | 0.190 |
Why?
|
| Dendritic Spines | 3 | 2021 | 56 | 0.180 |
Why?
|
| Exercise Test | 2 | 2020 | 241 | 0.180 |
Why?
|
| Neurologists | 1 | 2021 | 25 | 0.170 |
Why?
|
| Ketamine | 1 | 2025 | 229 | 0.170 |
Why?
|
| Adult | 12 | 2025 | 31266 | 0.170 |
Why?
|
| Stroke | 1 | 2009 | 1050 | 0.170 |
Why?
|
| Developmental Disabilities | 1 | 2026 | 771 | 0.170 |
Why?
|
| Clinical Trials as Topic | 1 | 2024 | 1131 | 0.160 |
Why?
|
| Gastroesophageal Reflux | 1 | 2023 | 333 | 0.160 |
Why?
|
| Gastrointestinal Diseases | 1 | 2023 | 340 | 0.150 |
Why?
|
| Chromosome Disorders | 1 | 2021 | 316 | 0.150 |
Why?
|
| Genome, Human | 1 | 2026 | 1322 | 0.150 |
Why?
|
| Chromosome Duplication | 1 | 2019 | 147 | 0.140 |
Why?
|
| Disease Progression | 1 | 2024 | 2202 | 0.140 |
Why?
|
| Physicians | 1 | 2024 | 635 | 0.130 |
Why?
|
| Cognition Disorders | 1 | 2018 | 559 | 0.110 |
Why?
|
| Double-Blind Method | 3 | 2025 | 1625 | 0.100 |
Why?
|
| Dendrites | 1 | 2013 | 182 | 0.090 |
Why?
|
| Constipation | 2 | 2023 | 130 | 0.090 |
Why?
|
| DNA Copy Number Variations | 2 | 2024 | 1028 | 0.070 |
Why?
|
| Hemiplegia | 1 | 2009 | 42 | 0.070 |
Why?
|
| Causality | 1 | 2009 | 91 | 0.070 |
Why?
|
| Carotid Artery, Internal | 1 | 2009 | 56 | 0.070 |
Why?
|
| Cerebral Angiography | 1 | 2009 | 107 | 0.070 |
Why?
|
| Signal Transduction | 1 | 2021 | 4668 | 0.070 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2009 | 64 | 0.070 |
Why?
|
| Mice | 5 | 2024 | 18203 | 0.070 |
Why?
|
| Middle Cerebral Artery | 1 | 2009 | 115 | 0.070 |
Why?
|
| Cell Differentiation | 2 | 2023 | 1921 | 0.070 |
Why?
|
| LIM-Homeodomain Proteins | 1 | 2007 | 31 | 0.070 |
Why?
|
| Bromodeoxyuridine | 1 | 2007 | 56 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2007 | 57 | 0.070 |
Why?
|
| Cerebral Ventricles | 1 | 2007 | 83 | 0.070 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2009 | 274 | 0.060 |
Why?
|
| In Situ Hybridization | 1 | 2007 | 445 | 0.060 |
Why?
|
| In Vitro Techniques | 1 | 2007 | 809 | 0.060 |
Why?
|
| Models, Neurological | 1 | 2007 | 208 | 0.060 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2026 | 24 | 0.060 |
Why?
|
| Cerebrovascular Circulation | 1 | 2009 | 485 | 0.060 |
Why?
|
| Embryo, Mammalian | 1 | 2007 | 414 | 0.060 |
Why?
|
| Nonlinear Dynamics | 1 | 2025 | 57 | 0.060 |
Why?
|
| Range of Motion, Articular | 1 | 2025 | 80 | 0.060 |
Why?
|
| Cell Cycle | 1 | 2007 | 595 | 0.060 |
Why?
|
| Endpoint Determination | 1 | 2024 | 57 | 0.050 |
Why?
|
| Pregnanolone | 1 | 2024 | 8 | 0.050 |
Why?
|
| Anticoagulants | 1 | 2009 | 600 | 0.050 |
Why?
|
| Animals | 5 | 2024 | 33873 | 0.050 |
Why?
|
| Genetic Heterogeneity | 1 | 2024 | 133 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 4653 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2007 | 568 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2024 | 12908 | 0.050 |
Why?
|
| Motor Skills | 1 | 2024 | 70 | 0.050 |
Why?
|
| Cross-Over Studies | 1 | 2025 | 329 | 0.050 |
Why?
|
| Linear Models | 1 | 2025 | 692 | 0.050 |
Why?
|
| Congresses as Topic | 1 | 2024 | 187 | 0.050 |
Why?
|
| Vigabatrin | 1 | 2023 | 19 | 0.050 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2023 | 61 | 0.050 |
Why?
|
| Spasm | 1 | 2023 | 46 | 0.050 |
Why?
|
| Cell Cycle Proteins | 1 | 2007 | 698 | 0.050 |
Why?
|
| Longevity | 1 | 2024 | 176 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2018 | 3869 | 0.050 |
Why?
|
| Child Behavior | 1 | 2024 | 236 | 0.050 |
Why?
|
| Age Factors | 1 | 2009 | 2847 | 0.050 |
Why?
|
| Sequence Deletion | 1 | 2024 | 519 | 0.050 |
Why?
|
| Consensus | 1 | 2024 | 528 | 0.050 |
Why?
|
| Mice, Transgenic | 1 | 2007 | 2338 | 0.050 |
Why?
|
| Exons | 1 | 2024 | 761 | 0.040 |
Why?
|
| Sleep Wake Disorders | 1 | 2024 | 204 | 0.040 |
Why?
|
| Patient Acuity | 1 | 2021 | 66 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2025 | 1623 | 0.040 |
Why?
|
| Time-to-Treatment | 1 | 2023 | 213 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2023 | 331 | 0.040 |
Why?
|
| Parent-Child Relations | 1 | 2022 | 255 | 0.040 |
Why?
|
| ras Proteins | 1 | 2021 | 146 | 0.040 |
Why?
|
| Research Design | 1 | 2024 | 718 | 0.040 |
Why?
|
| Anticonvulsants | 1 | 2023 | 384 | 0.040 |
Why?
|
| Alleles | 1 | 2024 | 1668 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2021 | 304 | 0.040 |
Why?
|
| Interviews as Topic | 1 | 2021 | 440 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2026 | 1092 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2026 | 1558 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2024 | 2307 | 0.040 |
Why?
|
| Health Status | 1 | 2021 | 384 | 0.040 |
Why?
|
| Gastrointestinal Tract | 1 | 2021 | 224 | 0.040 |
Why?
|
| Mental Health | 1 | 2022 | 382 | 0.040 |
Why?
|
| Parenting | 1 | 2022 | 356 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2007 | 2438 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2021 | 459 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2024 | 2337 | 0.030 |
Why?
|
| Motor Activity | 1 | 2019 | 499 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 3823 | 0.030 |
Why?
|
| Anxiety | 1 | 2022 | 1009 | 0.030 |
Why?
|
| Calibration | 1 | 2015 | 92 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 1158 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2024 | 5088 | 0.030 |
Why?
|
| Pregnancy | 1 | 2007 | 7499 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2026 | 3416 | 0.030 |
Why?
|
| Somatosensory Cortex | 1 | 2013 | 56 | 0.020 |
Why?
|
| Depression | 1 | 2022 | 1327 | 0.020 |
Why?
|
| Genotype | 1 | 2018 | 2610 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2024 | 8565 | 0.020 |
Why?
|
| Middle Aged | 2 | 2024 | 28494 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 5230 | 0.020 |
Why?
|
| Aged | 1 | 2024 | 20956 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2018 | 17672 | 0.010 |
Why?
|